RegeneRx Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of therapeutic peptide, thymosin beta 4, for tissue and organ protection, repair, and regeneration. The company is developing RGN-259, a preservative-free topical eye drop for regeneration of corneal tissues damaged by injury, disease, or other pathology; RGN-352, an injectable formulation to treat cardiovascular diseases, central and peripheral nervous system diseases, and other medical indications; and RGN-137, a topical gel for dermal wounds and reduction of scar tissue. It has strategic partnerships with Lee's Pharmaceutical Group and GtreeBNT Co., Ltd. The company was formerly known as Alpha 1 Biomedicals, Inc. and changed its name to RegeneRx Biopharmaceuticals, Inc. in 2000. RegeneRx Biopharmaceuticals, Inc. was incorporated in 1982 and is based in Rockville, Maryland. The 2025 version of the report offers detailed insights into the company's strategies, developments, outlook and drivers. In addition to SWOT Analysis and Financial Overview, the report analyzes key projects, business description, products, services, brands, operating locations, subsidiaries and affiliates of RegeneRx Biopharmaceuticals, Inc..
RegeneRx Biopharmaceuticals, Inc. business operations across the value chain are included. Further, all major operating and planned locations, related contacts, details of subsidiaries and partnerships of RegeneRx Biopharmaceuticals, Inc. are also analyzed.
Detailed SWOT Analysis of the company including key strengths and weaknesses of RegeneRx Biopharmaceuticals, Inc. , on which it can build its business along with potential opportunities and threats in the near to medium term future are detailed.
Key employees of the company including the management team and board of directors are listed with their designations. Further, statistics on key parameters such as employee count, organization structure etc is provided.
Financial analysis of RegeneRx Biopharmaceuticals, Inc. including key ratios, income statement, cash flow statement and balance sheet are provided for the company. In addition, Key historical events, summary analysis of RegeneRx Biopharmaceuticals, Inc. and all latest updates of the company are provided.
The 2025 version of RegeneRx Biopharmaceuticals, Inc. report is presented after intensive primary and secondary research processes and it presents the insights in a complete impartial and reader friendly format.
TABLE OF CONTENTS
1.1 List of Tables
1.2 List of Figures
2 Introduction to the Company
2.1 RegeneRx Biopharmaceuticals, Inc.- Key Facts
2.2 RegeneRx Biopharmaceuticals, Inc.- Geographic Locations
2.3 RegeneRx Biopharmaceuticals, Inc.- Subsidiaries and Affiliates
2.4 RegeneRx Biopharmaceuticals, Inc.- Business Divisions
2.5 RegeneRx Biopharmaceuticals, Inc.- Key Employees
2.5.1 Management Team
2.5.2 Board of Directors
3. RegeneRx Biopharmaceuticals, Inc. Strategic Analysis Review
3.1 RegeneRx Biopharmaceuticals, Inc.- Key Strategies
3.2 RegeneRx Biopharmaceuticals, Inc.- Company Outlook Statement
3.3 RegeneRx Biopharmaceuticals, Inc.- SWOT Analysis
3.3.1 RegeneRx Biopharmaceuticals, Inc.- Key Strengths
3.3.2 RegeneRx Biopharmaceuticals, Inc.- Key Weaknesses
3.3.3 RegeneRx Biopharmaceuticals, Inc.- Potential Opportunities
3.3.4 RegeneRx Biopharmaceuticals, Inc.- Potential Threats
3.4 RegeneRx Biopharmaceuticals, Inc.- Key Competitors
4. Business Description of the Company
4.1 RegeneRx Biopharmaceuticals, Inc.- Business Overview
4.2 RegeneRx Biopharmaceuticals, Inc.- Operations by Segment
5 Products and Services Details
5.1 RegeneRx Biopharmaceuticals, Inc.- Key Products
5.2 RegeneRx Biopharmaceuticals, Inc.- Key Service Areas
5.3 RegeneRx Biopharmaceuticals, Inc.- Key Brands
6 Company Developments
6.1 RegeneRx Biopharmaceuticals, Inc.- Company History
6.2 RegeneRx Biopharmaceuticals, Inc.- Latest Developments
7 Financial Analysis
7.1 RegeneRx Biopharmaceuticals, Inc.- Income Statements
7.2 RegeneRx Biopharmaceuticals, Inc.- Balance Sheet
7.3 RegeneRx Biopharmaceuticals, Inc.- Cash Flow Statements
8 Competitors and Industry Analysis
8.1 RegeneRx Biopharmaceuticals, Inc.- Direct Competitors
8.2 RegeneRx Biopharmaceuticals, Inc.- Competitor Financial Ratios comparison
8.3 RegeneRx Biopharmaceuticals, Inc.- Competitor Stock Charts Comparison
8.4 RegeneRx Biopharmaceuticals, Inc.- Industry Analysis
9 Appendix
9.1 About SWOTreports
9.2 Sources and Methodology
9.3 Contact Information
P.S.Financial Analysis will be provided only for companies reporting financial data.
At SWOT Reports, we understand the importance of informed decision-making in today's dynamic business landscape. To help you experience the depth and quality of our market research reports, we offer complimentary samples tailored to your specific needs.
Start Now! Please fill the form below for your free sample.
Evaluate Our Expertise: Our reports are crafted by industry experts and seasoned analysts. Requesting a sample allows you to assess the depth of research and the caliber of insights we provide.
Tailored to Your Needs: Let us know your industry, market segment, or specific topic of interest. Our free samples are customized to ensure relevance to your business objectives.
Witness Actionable Insights: See firsthand how our reports go beyond data, offering actionable insights and strategic recommendations that can drive your business forward.
Embark on your journey towards strategic decision-making by requesting a free sample from SWOT Reports. Experience the caliber of insights that can transform the way you approach your business challenges.
Gain valuable insights into the company for academic or business research purposes with this comprehensive profile. Key elements, such as SWOT analysis and corporate strategy, are included to support your research needs effectively.
Customer and Supplier Identification: Analyze the company’s business structure, operations, major products, services, and strategies to identify potential customers and suppliers.
Leverage a detailed SWOT analysis to understand and evaluate your competitors' business structures, strategies, and core performance metrics. This analysis offers an up-to-date and objective perspective on the company’s strengths, weaknesses, opportunities, and threats.
Didn’t find what you’re looking for? TALK TO OUR ANALYST TEAM
Need something within your budget? NO WORRIES! WE GOT YOU COVERED!